Cargando…

Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase

LARGE1 is a bifunctional glycosyltransferase responsible for generating a long linear polysaccharide termed matriglycan that links the cytoskeleton and the extracellular matrix and is required for proper muscle function. This matriglycan polymer is made with an alternating pattern of xylose and gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Michael, Diskin, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746966/
https://www.ncbi.nlm.nih.gov/pubmed/36512577
http://dx.doi.org/10.1371/journal.pone.0278713
_version_ 1784849482985242624
author Katz, Michael
Diskin, Ron
author_facet Katz, Michael
Diskin, Ron
author_sort Katz, Michael
collection PubMed
description LARGE1 is a bifunctional glycosyltransferase responsible for generating a long linear polysaccharide termed matriglycan that links the cytoskeleton and the extracellular matrix and is required for proper muscle function. This matriglycan polymer is made with an alternating pattern of xylose and glucuronic acid monomers. Mutations in the LARGE1 gene have been shown to cause life-threatening dystroglycanopathies through the inhibition of matriglycan synthesis. Despite its major role in muscle maintenance, the structure of the LARGE1 enzyme and how it assembles in the Golgi are unknown. Here we present the structure of LARGE1, obtained by a combination of X-ray crystallography and single-particle cryo-EM. We found that LARGE1 homo-dimerizes in a configuration that is dictated by its coiled-coil stem domain. The structure shows that this enzyme has two canonical GT-A folds within each of its catalytic domains. In the context of its dimeric structure, the two types of catalytic domains are brought into close proximity from opposing monomers to allow efficient shuttling of the substrates between the two domains. Together, with putative retention of matriglycan by electrostatic interactions, this dimeric organization offers a possible mechanism for the ability of LARGE1 to synthesize long matriglycan chains. The structural information further reveals the mechanisms in which disease-causing mutations disrupt the activity of LARGE1. Collectively, these data shed light on how matriglycan is synthesized alongside the functional significance of glycosyltransferase oligomerization.
format Online
Article
Text
id pubmed-9746966
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-97469662022-12-14 Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase Katz, Michael Diskin, Ron PLoS One Research Article LARGE1 is a bifunctional glycosyltransferase responsible for generating a long linear polysaccharide termed matriglycan that links the cytoskeleton and the extracellular matrix and is required for proper muscle function. This matriglycan polymer is made with an alternating pattern of xylose and glucuronic acid monomers. Mutations in the LARGE1 gene have been shown to cause life-threatening dystroglycanopathies through the inhibition of matriglycan synthesis. Despite its major role in muscle maintenance, the structure of the LARGE1 enzyme and how it assembles in the Golgi are unknown. Here we present the structure of LARGE1, obtained by a combination of X-ray crystallography and single-particle cryo-EM. We found that LARGE1 homo-dimerizes in a configuration that is dictated by its coiled-coil stem domain. The structure shows that this enzyme has two canonical GT-A folds within each of its catalytic domains. In the context of its dimeric structure, the two types of catalytic domains are brought into close proximity from opposing monomers to allow efficient shuttling of the substrates between the two domains. Together, with putative retention of matriglycan by electrostatic interactions, this dimeric organization offers a possible mechanism for the ability of LARGE1 to synthesize long matriglycan chains. The structural information further reveals the mechanisms in which disease-causing mutations disrupt the activity of LARGE1. Collectively, these data shed light on how matriglycan is synthesized alongside the functional significance of glycosyltransferase oligomerization. Public Library of Science 2022-12-13 /pmc/articles/PMC9746966/ /pubmed/36512577 http://dx.doi.org/10.1371/journal.pone.0278713 Text en © 2022 Katz, Diskin https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Katz, Michael
Diskin, Ron
Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase
title Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase
title_full Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase
title_fullStr Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase
title_full_unstemmed Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase
title_short Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase
title_sort structural basis for matriglycan synthesis by the large1 dual glycosyltransferase
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746966/
https://www.ncbi.nlm.nih.gov/pubmed/36512577
http://dx.doi.org/10.1371/journal.pone.0278713
work_keys_str_mv AT katzmichael structuralbasisformatriglycansynthesisbythelarge1dualglycosyltransferase
AT diskinron structuralbasisformatriglycansynthesisbythelarge1dualglycosyltransferase